Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Major components of the direct medical costs of alpha1-antitrypsin deficiency.

Chest - 1 Sept 2003

Mullins C Daniel, Wang Junling, Stoller James K

Abstract excerpt

STUDY OBJECTIVES: To examine the sources of the direct medical costs of alpha(1)-antitrypsin (AAT) deficiency based on survey data from affected individuals. BACKGROUND: Prior research has reported the total cost of AAT deficiency but has not examined the specific components of the direct medical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha 1-Antitrypsin Deficiency
Share to Costs and Cost Analysis
Share to Health Care Costs

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Health Surveys

Share to Insurance, Health

Share to Mathematical Computing

Share to Patient Care Team

Share to Statistics, Nonparametric

Source

Identifiers

PMID: 12970004
DOI: 10.1378/chest.124.3.826

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12970004-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Major components of the direct medical costs of alpha1-antitrypsin deficiency.PMID 12970004Read ↗

The direct medical costs of alpha(1)-antitrypsin deficiency.Semantic proximity Read ↗

Medical Costs of Alpha-1 Antitrypsin Deficiency-Associated COPD in the United StatesSemantic proximity Read ↗

Estimated Costs for Duchenne Muscular Dystrophy Care in BrazilSemantic proximity Read ↗

Estimated costs for Duchenne muscular dystrophy care in BrazilSemantic proximity Read ↗

Estimating Direct Cost of Cystic Fibrosis Care Using Irish Registry Healthcare Resource Utilisation Data, 2008-2012.Semantic proximity Read ↗

Cost-effectiveness of population screening for alpha-1 antitrypsin deficiency: a decision analysis.Semantic proximity Read ↗

Household costs in the United States for accommodating functional impairments associated with Duchenne muscular dystrophy: results from a caregiver surveySemantic proximity Read ↗

The cost of severe haemophilia in Europe: the CHESS studySemantic proximity Read ↗

Pharmacoeconomic analyses of azathioprine, methotrexate and prospective pharmacogenetic testing for the management of inflammatory bowel disease.Semantic proximity Read ↗

Economic burden in the management of transfusion-dependent thalassaemia patients in Malaysia from a societal perspectiveSemantic proximity Read ↗

Economic impact of juvenile idiopathic arthritisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.